Perspective Therapeutics, Inc. (CATX)
3.18
-0.12
(-3.64%)
USD |
NYAM |
Aug 24, 16:00
3.18
0.00 (0.00%)
After-Hours: 20:00
Perspective Therapeutics Total Liabilities (Quarterly) : 68.16M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 68.16M |
| March 31, 2026 | 63.33M |
| December 31, 2025 | 67.31M |
| September 30, 2025 | 52.61M |
| June 30, 2025 | 45.03M |
| March 31, 2025 | 44.70M |
| December 31, 2024 | 59.44M |
| September 30, 2024 | 62.68M |
| June 30, 2024 | 44.92M |
| March 31, 2024 | 48.40M |
| December 31, 2023 | |
| September 30, 2023 | 11.75M |
| June 30, 2023 | 11.49M |
| March 31, 2023 | 9.617M |
| June 30, 2022 | 3.162M |
| March 31, 2022 | 2.912M |
| December 31, 2021 | 2.861M |
| September 30, 2021 | 2.951M |
| June 30, 2021 | 3.01M |
| March 31, 2021 | 3.182M |
| December 31, 2020 | 2.74M |
| September 30, 2020 | 2.93M |
| June 30, 2020 | 2.976M |
| March 31, 2020 | 3.144M |
| December 31, 2019 | 2.792M |
| Date | Value |
|---|---|
| September 30, 2019 | 3.169M |
| June 30, 2019 | 1.742M |
| March 31, 2019 | 1.968M |
| December 31, 2018 | 2.246M |
| September 30, 2018 | 2.235M |
| June 30, 2018 | 2.425M |
| March 31, 2018 | 1.706M |
| December 31, 2017 | 1.507M |
| September 30, 2017 | 1.635M |
| June 30, 2017 | 1.667M |
| March 31, 2017 | 1.694M |
| December 31, 2016 | 1.418M |
| September 30, 2016 | 1.712M |
| June 30, 2016 | 1.701M |
| March 31, 2016 | 2.271M |
| December 31, 2015 | 2.193M |
| September 30, 2015 | 2.067M |
| June 30, 2015 | 2.221M |
| March 31, 2015 | 1.988M |
| December 31, 2014 | 2.057M |
| September 30, 2014 | 2.115M |
| June 30, 2014 | 2.594M |
| March 31, 2014 | 2.546M |
| December 31, 2013 | 1.699M |
| September 30, 2013 | 1.920M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 46.19M |
| MiMedx Group, Inc. | 65.00M |
| ABVC BioPharma, Inc. | 7.131M |
| Enovis Corp. | 2.287B |
| Edwards Lifesciences Corp. | 3.142B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 392.02M |
| Shareholders Equity (Quarterly) | 323.86M |
| Debt to Equity Ratio | 0.0122 |
| Current Ratio | 6.609 |
| Net Debt Paydown Yield | -0.01% |